Table 1: Patient characteristics and preoperative data
|
Overall (n=232) |
Minor (n=211) |
Major (n=21) |
p |
| Age (years) |
65 ± 9.73 |
65 ± 9.9 |
66 ± 8.7 |
0.749 |
| Gender (M:F) |
183:59 |
128 : 55 |
17 : 4 |
0,424 |
| BMI |
26 ± 3.85 |
26.5 ± 3.92 |
24.64 ± 3.87 |
0.117 |
| MELD score |
9 ± 1.67 |
8.66 ± 1.72 |
7.85 ± 0.90 |
0.009* |
| Preoperative INR |
1.12 ± 0.83 |
1.13 ± 0.84 |
1.08 ± 0.55 |
0.035* |
| Preoperative PLT |
166,698 ± 54,299 |
164,174 ± 53,241 |
203,384 ± 58,471 |
0.035* |
|
N (%) |
|
|
|
| Cirrhosis |
232 (100%) |
|
|
ns |
| Post-viral |
197 (84.91%) |
|
|
|
| HBV |
57 (24.57%) |
52 (24.6%) |
5 (23.8%) |
|
| HCV |
128 (65.51%) |
119 (56.4%) |
9 (42.9%) |
|
| HBV + HCV |
12 (5.17%) |
9 (4.26%) |
3 (14.3%) |
|
| Alcohol-related |
17 (7.32%) |
14 (6.63%) |
3 (14.3%) |
|
| Criptogenetic |
9 (3.87%) |
9 (4.26%) |
0 |
|
| Dismetabolic |
6 (2.58%) |
5 (2.36%) |
1 (4.7%) |
|
| Primary biliary cirrhosis |
1 (0.43%) |
1 (0.47%) |
0 |
|
| Hemochromatosis |
2 (0.86%) |
2 (0.95%) |
0 |
|
| Child-Pugh |
|
|
|
|
| A |
227 (97.84%) |
206 (97.6%) |
21 (100%) |
ns |
| B |
5 (2.15%) |
5 (2.4%) |
0 |
|
| C |
0 (0%) |
0 |
0 |
|
BMI: Body Mass Index; MELD: Model of End Stage Liver Disease; PLT: Platelet; HBV: Hepatits B Virus; HCV: Hepatitis C Virus